Answers are grounded in this paper and cite their sources.
Bridging structural discontinuities between disparate protein families is a fundamental challenge in multi-target design. We present a generative artificial intelligence (AI) platform for the non-linear interpolation of cross-family kinase space to simultaneously modulate innate (interleukin-1 receptor-associated kinase 4, IRAK4) and adaptive (tyrosine kinase 2, TYK2) immunity. Utilizing a variational autoencoder−recurrent neural network (VAE−RNN) model within the POLYGON framework, we successfully navigated high-dimensional latent space through an iterative “sampling−scoring−refocusing” strategy. This approach bypassed the geometric limitations of traditional pharmacophore merging, leading to the rational discovery of a novel spirocyclic scaffold with significant structural novelty (Tanimoto similarity <0.45). Integration of WaterMap-based optimization and proteolysis-targeting chimera (PROTAC) conjugation yielded C-8-014, a potent dual-target degrader achieving nanomolar potency and efficient degradation of both kinases. This study demonstrates a validated closed-loop methodology for navigating “unreachable” regions of the kinome, providing a paradigm-shifting approach for cross-family chemical design and a powerful molecular tool for chemical biology.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: